Eris Lifesciences (BOM:540596) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences ROE % Adjusted to Book Value?

Eris Lifesciences's ROE % for the quarter that ended in Dec. 2023 was 17.04%. Eris Lifesciences's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Eris Lifesciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.

Eris Lifesciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Eris Lifesciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences ROE % Adjusted to Book Value Chart

Eris Lifesciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.75

6.28

4.74

4.75

5.26

Eris Lifesciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	3.37	-	4.14	-

Competitive Comparison of Eris Lifesciences's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eris Lifesciences's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's ROE % Adjusted to Book Value falls into.

Eris Lifesciences ROE % Adjusted to Book Value Calculation

Eris Lifesciences's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	18.62%	/	3.54
	=	5.26%

Eris Lifesciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	17.04%	/	N/A
	=	N/A

Eris Lifesciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences (BOM:540596) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

ERIS:India

Address

Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.eris.co.in

Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (BOM:540596) Headlines

No Headlines